Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors

A series of 3,4-diaminobenzoyl compounds have been designed and synthesized as novel antithrombotic agents. Thereinto, compound 7b is a highly potent, selective FXa inhibitor with excellent in vivo antithrombotic activity.158